Developing U.S. oversight strategies for nanobiotechnology: Learning from past oversight experiences

Medicine & Life Sciences

• Genetically Modified Organisms 82%
• United States Occupational Safety and Health Administration 73%
• United States Department of Agriculture 72%
• United States Environmental Protection Agency 72%
• State Government 71%
• Food Supply 63%
• Nanotechnology 60%
• Agriculture 58%
• National Institutes of Health (U.S.) 52%
• United States Food and Drug Administration 50%
• Workplace 48%
• Genetic Therapy 46%
• Industry 46%
• Learning 37%
• Research Personnel 35%
• Technology 33%
• Equipment and Supplies 30%
• Pharmaceutical Preparations 20%

Social Sciences

• Chemicals in the workplace 100%
• gene therapy 78%
• food supply 63%
• Occupational safety & health 62%
• Medical devices 62%
• nanotechnology 55%
• Environmental protection agencies 55%
• Occupational health 54%
• pharmaceutical 46%
• agriculture 42%
• industry 29%
• health 23%
• learning 17%
• experience 15%